1. Barnes, J. M., C. S. Heymann, N. S. Galbraith, andG. R. O'Moore: A clinical trial of Glenn type 3 attenuated poliovirus vaccine. Arch. ges. Virusforsch.20, 296 (1967).
2. Dulbecco, E.: Poliovirus mutations seen from the point of view of molecular biology. In: ?Poliomyelitis. Papers and Discussions presented at the 5th Int. Polio Conf.?, p. 21. Philadelphia-Montreal: Lippincott Co., 1960a.
3. 2nd Int. Conf. Scient. Publ. 50;R. Dulbecco,1960
4. Dulbecco, E., andM. Vogt: Study of the mutability of d lines of polioviruses. Virology5, 220 (1958).
5. Elbert, L. B., M. P. Chumakov, G. L. Krutyanskaya, N. M. Ralph, andA. V. Tyufanov: Investigation of some possibilities of producing type 3 vaccine poliovirus with greater genetic stability. I. Acta virol.12, 193 (1968).